NuFACTOR Introduces Online Immune Globulin Therapy Tracking System for Homecare Patients
Posted on: Wednesday, 19 July 2006, 15:00 CDT
NuFACTOR, a specialty pharmacy services company, went live today with its Immune Globulin Treatment Tracker (IGTT), an online system for homecare patients to independently track, monitor and report their immune globulin therapy. NuFACTOR is a division of the Temecula-headquartered healthcare corporation FFF Enterprises, the nation's largest distributor of immune globulin products, vaccines and other biopharmaceuticals.
NuFACTOR provides services to patients with chronic diseases who are treated with infusion therapies in their homes. Immune globulin, made from human plasma, is used to treat many conditions, including primary immune deficiency diseases, neuropathies, myositis, Guillain-Barre syndrome and others.
IGTT represents a new, collaborative approach for healthcare consumers who are increasingly requesting a more active role in managing their treatment plans in cooperation with their healthcare providers.
"IG Treatment Tracker is the first Web-based system in the nation that puts consumers in control of their home immune globulin therapy," said Patrick M. Schmidt, president and CEO of NuFACTOR and FFF Enterprises. "The system improves communication between patients and their healthcare providers by providing a comprehensive view of the patient's treatment and related health issues between office visits. The increased flow of information helps patients and their physicians more effectively manage treatment and compliance."
IG Treatment Tracker allows patients who regularly infuse immune globulin to maintain complete infusion and health logs, including product lot numbers, infusion method, amounts and rates, exact administration sites on a body image, infusion attempts and reactions, and other medical information. Patients can retrieve their securely stored information at their discretion to share with physicians and other healthcare providers.
IG Treatment Tracker stores all patient information in a private, HIPAA-compliant record that patients can access and update at any time. No additional program downloading is necessary, and the only technical requirement is Internet access.
"We are pleased to be able to provide IG Treatment Tracker as a complimentary service to NuFACTOR patients," Schmidt said. "The freedom and control the system offers to help healthcare consumers is empowering."
For more information about IG Treatment Tracker, visit www.nufactor.com or call NuFACTOR at 800-323-6832.
About NuFACTOR
FFF Enterprises, the nation's largest immune globulin distributor, established NuFACTOR, its specialty pharmacy services division, in 1995. NuFACTOR was founded on the principles of responsibly listening and respectfully responding to healthcare consumers. NuFACTOR is dedicated to solving the chronic problems of affordability, availability and safety in disease state management for chronically ill patients. The company is deeply committed to the philosophy of providing philanthropic support to the patient communities it serves.
Source: Business Wire
Related Articles
- Healthcare Industry Celebrates 25 Years of Advanced Pain Management With PCA Infusion System
- Hospira Advances Patient Safety With New GemStar(R) SP Infusion System
- New Hope in Immunodeficiency Treatment for Improved Tolerability and Convenience in the Use of Immune Globulin Intravenous (Human) 10% Liquid (Privigen(R))
- FDA Approves Rhophylac(R) for the Treatment of Immune Thrombocytopenic Purpura (ITP)
- FFF Enterprises Launches Magazine for Immune Globulin Community
- First Patient Receives Targeted Renal Therapy With FlowMedica's Benephit(TM) Delta Infusion System
- Benephit Delta Infusion System Receives 510k Clearance
- Benephit Infusion System To Be Studied in Patients With Chronic Kidney Disease Undergoing Cardiovascular Procedures
- FlowMedica Announces New Physician-Sponsored Study of Its Benephit Infusion System in Patients With Renal Insufficiency
 |
 |
User Comments (0)
RSS Feeds